IRI and Kline, a global market research and management consulting firm, have established an exclusive alliance to serve the worldwide, over-the-counter (OTC) drug and consumer health care industries. This alliance includes an unparalleled, global range of thought leadership on stimulating topics in consumer health care. As part of this collaborative relationship, IRI contributes its granular, widely recognized, point-of-sale (POS) market data, related insights and thought leadership while Kline provides its unmatched historical database, global network, and a 360-degree view of the complex OTC drug market, including comprehensive channel coverage and vast expertise in the area of Rx-to-OTC switches.
Read their latest insights into OTC health care in the papers below.
Pain Management Devices: Coexist or Supplant OTC Pain Medicines?
Read about the future of pain management devices, including the technologies being used and the expected impact on the OTC market.
“Natural” Trends and Drivers in the Self-care Space
Discover the latest market and retail trends, the competitive landscape, the future for natural OTCs, and how to win in this growing market.
Recent OTC Innovation: Observations and Implications for Future Growth
Understand key success factors with new OTC product launches and how to support their growth post launch.
Brain Health: Unlocking White Space Potential for the OTC Industry
Explore current opportunities for OTC marketers in the area of brain health as well as the future outlook.
Flipping the Switch: Disparity between the United States and Rest of World
Learn about the Rx-to-OTC switch environment globally, as well as which Rx products in the U.S. are likely to switch in the future.